{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:44:50Z","timestamp":1788425090488,"version":"build-2803163510"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":365,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030-122045"],"award-info":[{"award-number":["310030-122045"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HD057033"],"award-info":[{"award-number":["1R01HD057033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Host immune response to viral vectors, persistence of nonintegrating vectors, and sustained transgene expression are among the major challenges in gene therapy. To overcome these hurdles, we successfully used minicircle (MC) naked-DNA vectors devoid of any viral or bacterial sequences for the long-term treatment of murine phenylketonuria, a model for a genetic liver defect. MC-DNA vectors expressed the murine phenylalanine hydroxylase (<jats:italic toggle=\"yes\">Pah<\/jats:italic>) complementary DNA (cDNA) from a liver-specific promoter coupled to a <jats:italic toggle=\"yes\">de novo<\/jats:italic> designed hepatocyte-specific regulatory element, designated P3, which is a cluster of evolutionary conserved transcription factor binding sites. MC-DNA vectors were subsequently delivered to the liver by a single hydrodynamic tail vein (HTV) injection. The MC-DNA vector normalized blood phenylalanine concomitant with reversion of hypopigmentation in a dose-dependent manner for more than 1 year, whereas the corresponding parental plasmid did not result in any phenylalanine clearance. MC vectors persisted in an episomal state in the liver consistent with sustained transgene expression and hepatic PAH enzyme activity without any apparent adverse effects. Moreover, 14-20% of all hepatocytes expressed transgenic PAH, and the expression was observed exclusively in the liver and predominately around pericentral areas of the hepatic lobule, while there was no transgene expression in periportal areas. <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: This study demonstrates that MC technology offers an improved safety profile and has the potential for the genetic treatment of liver diseases. (Hepatology 2014;60:1035\u20131043)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.27104","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T12:59:40Z","timestamp":1393592380000},"page":"1035-1043","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":72,"title":["Treatment of phenylketonuria using minicircle-based naked-DNA gene transfer to murine liver"],"prefix":"10.1097","volume":"60","author":[{"given":"Hiu Man","family":"Viecelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Harbottle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suet Ping","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinee K.","family":"Chuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"VandenDriessche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary O.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Th\u00f6ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20250207","doi-asserted-by":"crossref","first-page":"14171427","DOI":"10.1016\/S0140-6736(10)60961-0","article-title":"Phenylketonuria.","volume":"376","author":"Blau","year":"2010","journal-title":"Lancet"},{"key":"R2-30-20250207","doi-asserted-by":"crossref","first-page":"12051210","DOI":"10.1093\/genetics\/134.4.1205","article-title":"Mouse models of human phenylketonuria.","volume":"134","author":"Shedlovsky","year":"1993","journal-title":"Genetics"},{"key":"R3-30-20250207","doi-asserted-by":"crossref","first-page":"587593","DOI":"10.1038\/sj.gt.3302684","article-title":"Administrationroute and genderindependent longterm therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adenoassociated virus 8 pseudotyped vectormediated gene transfer.","volume":"13","author":"Ding","year":"2006","journal-title":"Gene Ther"},{"key":"R4-30-20250207","doi-asserted-by":"crossref","first-page":"114122","DOI":"10.1002\/jgm.1543","article-title":"Complete restoration of phenylalanine oxidation in phenylketonuria mouse by a selfcomplementary adenoassociated virus vector.","volume":"13","author":"Yagi","year":"2011","journal-title":"J Gene Med"},{"key":"R5-30-20250207","doi-asserted-by":"crossref","first-page":"673681","DOI":"10.1038\/mt.2008.17","article-title":"Correction of murine PKU following AAVmediated intramuscular expression of a complete phenylalanine hydroxylating system.","volume":"16","author":"Ding","year":"2008","journal-title":"Mol Ther"},{"key":"R6-30-20250207","doi-asserted-by":"crossref","first-page":"457462","DOI":"10.1038\/sj.gt.3302678","article-title":"Complete correction of hyperphenylalaninemia following liverdirected, recombinant AAV28 vectormediated gene therapy in murine phenylketonuria.","volume":"13","author":"Harding","year":"2006","journal-title":"Gene Ther"},{"key":"R7-30-20250207","doi-asserted-by":"crossref","first-page":"278284","DOI":"10.1203\/01.PDR.0000132837.29067.0E","article-title":"Longterm enzymatic and phenotypic correction in the phenylketonuria mouse model by adenoassociated virus vectormediated gene transfer.","volume":"56","author":"Oh","year":"2004","journal-title":"Pediatr Res"},{"key":"R8-30-20250207","doi-asserted-by":"crossref","first-page":"10811086","DOI":"10.1038\/sj.gt.3302262","article-title":"Longterm correction of hyperphenylalaninemia by AAVmediated gene transfer leads to behavioral recovery in phenylketonuria mice.","volume":"11","author":"Mochizuki","year":"2004","journal-title":"Gene Ther"},{"key":"R9-30-20250207","doi-asserted-by":"crossref","first-page":"463477","DOI":"10.1089\/hum.2009.127","article-title":"Comparison of adenoassociated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria.","volume":"21","author":"Rebuffat","year":"2010","journal-title":"Hum Gene Ther"},{"key":"R10-30-20250207","doi-asserted-by":"crossref","first-page":"11091118","DOI":"10.1089\/hum.2007.072","article-title":"Gender differences in serotype 2 adenoassociated virus biodistribution after administration to rodent salivary glands.","volume":"18","author":"Voutetakis","year":"2007","journal-title":"Hum Gene Ther"},{"key":"R11-30-20250207","doi-asserted-by":"crossref","first-page":"699708","DOI":"10.1038\/mt.2011.287","article-title":"The AAV vector toolkit: poised at the clinical crossroads.","volume":"20","author":"Asokan","year":"2012","journal-title":"Mol Ther"},{"key":"R12-30-20250207","first-page":"341355","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges.","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat Rev Genet"},{"key":"R13-30-20250207","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1142658","article-title":"AAV vector integration sites in mouse hepatocellular carcinoma.","volume":"317","author":"Donsante","year":"2007","journal-title":"Science"},{"key":"R14-30-20250207","doi-asserted-by":"crossref","first-page":"316328","DOI":"10.1038\/nrg2971","article-title":"Stateoftheart genebased therapies: the road ahead.","volume":"12","author":"Kay","year":"2011","journal-title":"Nat Rev Genet"},{"key":"R15-30-20250207","doi-asserted-by":"crossref","first-page":"147161","DOI":"10.2174\/156652308784746440","article-title":"Episomal vectors for gene therapy.","volume":"8","author":"Ehrhardt","year":"2008","journal-title":"Curr Gene Ther"},{"key":"R16-30-20250207","doi-asserted-by":"crossref","first-page":"165171","DOI":"10.1038\/gt.2008.183","article-title":"Progress and prospects: the design and production of plasmid vectors.","volume":"16","author":"Gill","year":"2009","journal-title":"Gene Ther"},{"key":"R17-30-20250207","doi-asserted-by":"crossref","first-page":"549551","DOI":"10.1038\/nbt1399","article-title":"CpGfree plasmids confer reduced inflammation and sustained pulmonary gene expression.","volume":"26","author":"Hyde","year":"2008","journal-title":"Nat Biotechnol"},{"key":"R18-30-20250207","doi-asserted-by":"crossref","first-page":"13411349","DOI":"10.1038\/sj.gt.3300540","article-title":"A new DNA vehicle for nonviral gene delivery: supercoiled minicircle.","volume":"4","author":"Darquet","year":"1997","journal-title":"Gene Ther"},{"key":"R19-30-20250207","doi-asserted-by":"crossref","first-page":"2301823027","DOI":"10.1074\/jbc.M010873200","article-title":"An araCcontrolled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy.","volume":"276","author":"Bigger","year":"2001","journal-title":"J Biol Chem"},{"key":"R20-30-20250207","doi-asserted-by":"crossref","first-page":"12531269","DOI":"10.1002\/jgm.1243","article-title":"MinicircleDNA production by site specific recombination and proteinDNA interaction chromatography.","volume":"10","author":"Mayrhofer","year":"2008","journal-title":"J Gene Med"},{"key":"R21-30-20250207","doi-asserted-by":"crossref","first-page":"12871289","DOI":"10.1038\/nbt.1708","article-title":"A robust system for production of minicircle DNA vectors.","volume":"28","author":"Kay","year":"2010","journal-title":"Nat Biotechnol"},{"key":"R22-30-20250207","doi-asserted-by":"crossref","first-page":"12581266","DOI":"10.1038\/sj.gt.3300947","article-title":"Hydrodynamicsbased transfection in animals by systemic administration of plasmid DNA.","volume":"6","author":"Liu","year":"1999","journal-title":"Gene Ther"},{"key":"R23-30-20250207","doi-asserted-by":"crossref","first-page":"559565","DOI":"10.1016\/j.ymgme.2011.12.025","article-title":"Quantification of phenylalanine hydroxylase activity by isotopedilution liquid chromatographyelectrospray ionization tandem mass spectrometry.","volume":"105","author":"Heintz","year":"2012","journal-title":"Mol Genet Metab"},{"key":"R24-30-20250207","doi-asserted-by":"crossref","first-page":"2830328311","DOI":"10.1074\/jbc.M303986200","article-title":"Dwarfism and low insulinlike growth factor1 due to dopamine depletion in Pts mice rescued by feeding neurotransmitter precursors and H4biopterin.","volume":"278","author":"Elzaouk","year":"2003","journal-title":"J Biol Chem"},{"key":"R26-30-20250207","doi-asserted-by":"crossref","first-page":"337344","DOI":"10.1016\/j.ymthe.2005.03.025","article-title":"Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria.","volume":"12","author":"Hamman","year":"2005","journal-title":"Mol Ther"},{"key":"R27-30-20250207","doi-asserted-by":"crossref","first-page":"927935","DOI":"10.1038\/sj.gt.3302469","article-title":"Hydrodynamic liver gene transfer mechanism involves transient sinusoidal blood stasis and massive hepatocyte endocytic vesicles.","volume":"12","author":"Crespo","year":"2005","journal-title":"Gene Ther"},{"key":"R28-30-20250207","doi-asserted-by":"crossref","first-page":"101106","DOI":"10.1089\/hum.2009.212","article-title":"Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX.","volume":"22","author":"Schuttrumpf","year":"2011","journal-title":"Hum Gene Ther"},{"key":"R29-30-20250207","doi-asserted-by":"crossref","first-page":"548556","DOI":"10.1038\/sj.mt.6300399","article-title":"Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation.","volume":"16","author":"Chen","year":"2008","journal-title":"Mol Ther"},{"key":"R30-30-20250207","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1023\/B:MOLE.0000031363.35839.46","article-title":"Expression of a transgene encoded on a nonviral episomal vector is not subject to epigenetic silencing by cytosine methylation.","volume":"31","author":"Jenke","year":"2004","journal-title":"Mol Biol Rep"},{"key":"R31-30-20250207","doi-asserted-by":"crossref","first-page":"129137","DOI":"10.1038\/sj.gt.3302865","article-title":"Structural impact of hydrodynamic injection on mouse liver.","volume":"14","author":"Suda","year":"2007","journal-title":"Gene Ther"},{"key":"R32-30-20250207","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijpharm.2007.06.012","article-title":"Innate immune response induced by gene delivery vectors.","volume":"354","author":"Sakurai","year":"2008","journal-title":"Int J Pharm"},{"key":"R33-30-20250207","doi-asserted-by":"crossref","first-page":"225235","DOI":"10.1089\/hum.2010.113","article-title":"Muscle damage after delivery of naked plasmid DNA into skeletal muscles is batch dependent.","volume":"22","author":"Wooddell","year":"2011","journal-title":"Hum Gene Ther"},{"key":"R34-30-20250207","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1038\/gt.2011.215","article-title":"Minicircle DNA electrotransfer for efficient tissuetargeted gene delivery.","volume":"20","author":"Chabot","year":"2013","journal-title":"Gene Ther"},{"key":"R35-30-20250207","doi-asserted-by":"crossref","first-page":"594603","DOI":"10.1038\/sj.gt.3303096","article-title":"Direct comparison of hepatocytespecific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer.","volume":"15","author":"Jacobs","year":"2008","journal-title":"Gene Ther"},{"key":"R36-30-20250207","doi-asserted-by":"crossref","first-page":"515529","DOI":"10.1007\/s00109-010-0713-3","article-title":"Development of SMAR minicircles for enhanced and persistent transgene expression in the mouse liver.","volume":"89","author":"Argyros","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"R37-30-20250207","doi-asserted-by":"crossref","first-page":"495500","DOI":"10.1016\/S1525-0016(03)00168-0","article-title":"Minicircle DNA vectors devoid of bacterial DNA result in persistent and highlevel transgene expression in vivo.","volume":"8","author":"Chen","year":"2003","journal-title":"Mol Ther"},{"key":"R38-30-20250207","doi-asserted-by":"crossref","first-page":"450460","DOI":"10.1038\/mt.2010.249","article-title":"Minicircle DNAbased gene therapy coupled with immune modulation permits longterm expression of alphaLiduronidase in mice with mucopolysaccharidosis type I.","volume":"19","author":"Osborn","year":"2011","journal-title":"Mol Ther"},{"key":"R39-30-20250207","doi-asserted-by":"crossref","first-page":"505524","DOI":"10.1007\/s10541-005-0145-9","article-title":"On the biological significance of DNA methylation.","volume":"70","author":"Doerfler","year":"2005","journal-title":"Biochemistry (Mosc)"},{"key":"R40-30-20250207","doi-asserted-by":"crossref","first-page":"253257","DOI":"10.1038\/nature09165","article-title":"Conserved role of intragenic DNA methylation in regulating alternative promoters.","volume":"466","author":"Maunakea","year":"2010","journal-title":"Nature"},{"key":"R41-30-20250207","doi-asserted-by":"crossref","first-page":"21112119","DOI":"10.1038\/mt.2012.65","article-title":"The extragenic spacer length between the 5 and 3 ends of the transgene expression cassette affects transgene silencing from plasmidbased vectors.","volume":"20","author":"Lu","year":"2012","journal-title":"Mol Ther"},{"key":"R42-30-20250207","doi-asserted-by":"crossref","first-page":"131138","DOI":"10.1038\/mt.2012.244","article-title":"Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level.","volume":"21","author":"Gracey Maniar","year":"2013","journal-title":"Mol Ther"},{"key":"R43-30-20250207","doi-asserted-by":"crossref","first-page":"17351737","DOI":"10.1089\/10430349950017734","article-title":"High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.","volume":"10","author":"Zhang","year":"1999","journal-title":"Hum Gene Ther"},{"key":"R44-30-20250207","doi-asserted-by":"crossref","first-page":"491499","DOI":"10.1038\/mt.2008.294","article-title":"Imageguided, lobespecific hydrodynamic gene delivery to swine liver.","volume":"17","author":"Kamimura","year":"2009","journal-title":"Mol Ther"},{"key":"R45-30-20250207","doi-asserted-by":"crossref","first-page":"225230","DOI":"10.1038\/sj.cgt.7701119","article-title":"Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human.","volume":"15","author":"Khorsandi","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"R46-30-20250207","doi-asserted-by":"crossref","first-page":"756767","DOI":"10.1002\/bies.201000027","article-title":"Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.","volume":"32","author":"Izsvak","year":"2010","journal-title":"Bioessays"},{"key":"R47-30-20250207","doi-asserted-by":"crossref","first-page":"15931605","DOI":"10.1038\/gt.2008.113","article-title":"Persistent episomal transgene expression in liver following delivery of a scaffoldmatrix attachment region containing nonviral vector.","volume":"15","author":"Argyros","year":"2008","journal-title":"Gene Ther"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27104","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201409000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:17:05Z","timestamp":1738948625000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201409000-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27104","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}